topSkip to main content

Menu, Secondary

Menu Trigger

Menu

National Institutes of Health

Biomedical research funded by the National Institutes of Health (NIH) and performed at research universities helps assure U.S. leadership in the life sciences revolution of the 21st Century. Putting NIH on a sustained pathway to restore its purchasing power after a decade worth of loss to inflation and budget cuts is critical to sustaining the extraordinary progress in the improvement of human health of the past decades. Investment in NIH will continue to create jobs and strengthen the workforce, improve the lives—and quality of life—of millions of current and future patients, and help assure continuing U.S. economic and national security.

Sustained investment in biotechnology and genomics is crucial to the development of novel therapies for diseases, including: cancer, Alzheimer's, autism, and diabetes. The NIH also responds rapidly to public health emergencies and in support of biodefense, such as in the case of Ebola, Zika, and COVID-19.

 

One pager for advocacy focused on health and medical research.
While AAU would have liked to have seen an increase in NIH funding in FY24, we are pleased that Congress will soon be able to avoid a year-long continuing resolution which will ensure that the National Institutes of Health (NIH) can continue to fund new promising research projects.

An overview of the President's full proposed budget for FY25, including summaries and analyses for individual agencies.

Download the PDF

AAU submitted comments to the Department of Health and Human Services’ Office of Research Integrity regarding its notice of proposed rule making on Public Health Service Policies on Research Misconduct. AAU expressed concerns that the proposed regulations would “substantially increase – not decrease – the complexity of the research misconduct review process.”
As lawmakers consider measures related to securing federally funded research data and intellectual property, it is important to understand the current state of play for research security in the country to avoid new requirements that are duplicative, unnecessary, or counterproductive
AAU, and Associations sent a joint letter to House members in opposition to amendment #109 being offered by Rep. Andy Harris (R-MD), Rep. Michael Burgess (R-TX), Rep. Rich McCormick (R-GA), and Rep. Brad Wenstrup (R-OH) as part of the consideration of H.R. 5894, the Labor, Health, and Human Services, Education, and Related Agencies Appropriations Act for FY2024
AAU President Barbara R. Snyder applauds the Senate for voting today to confirm Monica Bertagnolli as the director of the National Institutes of Health.
AAU President Barbara R. Snyder sent a letter to leaders in the Senate encouraging “swift Senate floor action” on the nomination of Monica Bertagnolli as the next director of the National Institutes of Health.
AAU and COGR submitted joint comments to the NIH ahead of their upcoming workshop.
AAU joined a FASEB letter to Congress on increased federal support for scientific research with NHPs.